Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.


Abstract

•  The malignant character of RCC is reflected by higher XPA-210 expression as compared with oncocytomas and normal kidney. •  The ccRCC and papRCC subgroups had higher XPA-210 levels. •  XPA-210 could be considered a potential marker for the assessment of the proliferative activity in primary RCC.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013